PHLDB2 and malignant colon neoplasm: Our previous report also indicates that PHLDB2 overexpression counteracts the inhibitory effects of miR-29c-3p in cell migration and invasion, and also is associated with poorer metastasis-free survival of colon cancer patients [6].